Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 189

1.

Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant.

Ganetsky M, Babu KM, Salhanick SD, Brown RS, Boyer EW.

J Med Toxicol. 2011 Dec;7(4):281-7. doi: 10.1007/s13181-011-0178-y. Review.

2.

Dabigatran for stroke prevention in nonvalvular atrial fibrillation: focus in the geriatric population.

Brunetti L, Chen C, White J.

Consult Pharm. 2014 Mar;29(3):169-78. doi: 10.4140/TCP.n.2014.169. Review.

PMID:
24589766
3.

Dabigatran: will it change clinical practice?

Wartak SA, Bartholomew JR.

Cleve Clin J Med. 2011 Oct;78(10):657-64. doi: 10.3949/ccjm.78a.11021.

PMID:
21968472
4.

Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation.

Bendel SD, Bona R, Baker WL.

Adv Ther. 2011 Jun;28(6):460-72. doi: 10.1007/s12325-011-0025-1. Epub 2011 Apr 26. Review.

PMID:
21533567
5.

Dabigatran: a new chapter in anticoagulation.

Ahmed S, Levin V, Malacoff R, Martinez MW.

Cardiovasc Hematol Agents Med Chem. 2012 Jun;10(2):116-23. Review.

PMID:
22480286
6.

Implications of Dabigatran, a direct thrombin inhibitor, for oral surgery practice.

Davis C, Robertson C, Shivakumar S, Lee M.

J Can Dent Assoc. 2013;79:d74. Review.

7.

[Direct oral thrombin inhibitor, "dabigatran"].

Yasaka M.

Nihon Rinsho. 2013 Jan;71(1):113-8. Review. Japanese.

PMID:
23631181
8.

Spontaneous splenic hemorrhage after initiation of dabigatran (Pradaxa) for atrial fibrillation.

Moore CH, Snashall J, Boniface K, Scott J.

Am J Emerg Med. 2012 Nov;30(9):2082.e1-2. doi: 10.1016/j.ajem.2011.10.031. Epub 2011 Dec 23.

PMID:
22196949
9.

Pharmacokinetic and clinical implications of dabigatran use in severe renal impairment for stroke prevention in nonvalvular atrial fibrillation.

Mack DR, Kim JJ.

Ann Pharmacother. 2012 Jul-Aug;46(7-8):1105-10. doi: 10.1345/aph.1R057. Epub 2012 Jul 3. Review.

PMID:
22764329
10.

The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran.

Alikhan R, Rayment R, Keeling D, Baglin T, Benson G, Green L, Marshall S, Patel R, Pavord S, Rose P, Tait C.

Emerg Med J. 2014 Feb;31(2):163-8. doi: 10.1136/emermed-2012-201976. Epub 2013 Feb 22. Review.

11.

Review of recently approved alternatives to anticoagulation with warfarin for emergency clinicians.

Brem E, Koyfman A, Foran M.

J Emerg Med. 2013 Jul;45(1):143-9. doi: 10.1016/j.jemermed.2012.11.032. Epub 2013 Jan 30. Review.

PMID:
23375217
12.

Hospital-based clinical implications of the novel oral anticoagulant, dabigatran etexilate, in daily practice.

Wilcox R, Pendleton RC, Smock KJ, Rodgers GM.

Hosp Pract (1995). 2011 Aug;39(3):23-34. doi: 10.3810/hp.2011.08.576. Review.

PMID:
21881389
13.

Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin.

Berger R, Salhanick SD, Chase M, Ganetsky M.

Ann Emerg Med. 2013 Apr;61(4):475-9. doi: 10.1016/j.annemergmed.2013.02.008.

PMID:
23522810
14.

[Expectation to and problems of thrombin inhibitor].

Uchiyama S.

Rinsho Shinkeigaku. 2011 Nov;51(11):1004-6. Japanese.

PMID:
22277458
15.

Advances in anticoagulation: focus on dabigatran, an oral direct thrombin inhibitor.

Augoustides JG.

J Cardiothorac Vasc Anesth. 2011 Dec;25(6):1208-12. doi: 10.1053/j.jvca.2011.08.005. Epub 2011 Oct 7. Review.

PMID:
21982327
16.

Dabigatran use in a postoperative coronary artery bypass surgery patient with nonvalvular atrial fibrillation and heparin-PF4 antibodies.

Fieland D, Taylor M.

Ann Pharmacother. 2012 Jan;46(1):e3. doi: 10.1345/aph.1Q474. Epub 2011 Dec 27.

PMID:
22202498
17.

Evaluating and assessing dabigatran drug interactions.

Nguyen T, Wong E.

Consult Pharm. 2012 Jul;27(7):509-12. doi: 10.4140/TCP.n.2012.509.

PMID:
22910132
18.

Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation.

Berman JP, Halperin JL.

Hosp Pract (1995). 2013 Feb;41(1):37-48. doi: 10.3810/hp.2013.02.1006. Review.

PMID:
23466966
19.

Recent advances in antithrombotic therapy for stroke prevention in patients with atrial fibrillation.

Lenchus JD.

Hosp Pract (1995). 2013 Feb;41(1):49-60. doi: 10.3810/hp.2013.02.1007.

PMID:
23466967
20.

[Dabigatran, a new oral anticoagulant].

Uchiyama S.

Brain Nerve. 2011 Apr;63(4):411-5. Review. Japanese.

PMID:
21441645

Supplemental Content

Support Center